This company listing is no longer active
SMDC.F Stock Overview
Develops and markets personal telemedicine solutions in Israel, Europe, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
SHL Telemedicine Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 17.15 |
| 52 Week High | CHF 17.15 |
| 52 Week Low | CHF 17.15 |
| Beta | 0.89 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | 170.75% |
| 5 Year Change | n/a |
| Change since IPO | 84.41% |
Recent News & Updates
Recent updates
Shareholder Returns
| SMDC.F | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | -5.3% | 1.6% |
| 1Y | n/a | -17.4% | 11.7% |
Return vs Industry: Insufficient data to determine how SMDC.F performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how SMDC.F performed against the US Market.
Price Volatility
| SMDC.F volatility | |
|---|---|
| SMDC.F Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 8.1% |
| Market Average Movement | 8.1% |
| 10% most volatile stocks in US Market | 16.9% |
| 10% least volatile stocks in US Market | 4.1% |
Stable Share Price: SMDC.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine SMDC.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | n/a | Erez Nachtomy | www.shl-telemedicine.com |
SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. The company offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen’C, a personal cellular-digital 12-lead ECG transmitter device; Cardio’B, a portable device to transmit a 12-lead ECG; and Cardio Beeper 12/12, a hand-held ECG transmitter device for personal use that transmits a full ECG reading to the monitoring center. It also provides central communication module, a telecommunication device that transmits medical data to its telemedicine centers from various medical monitoring devices; TeleWeight, a trans-telephonic weight monitoring device for personal use; TelePress, a remote blood pressure monitoring device for personal use; TeleBreather, a remote electronic handheld device to test the working of lungs; and TelePulse Oximeter, an electronic handheld diagnostic device to measure the saturation level of oxygen in blood, as well as pulse rate.
SHL Telemedicine Ltd. Fundamentals Summary
| SMDC.F fundamental statistics | |
|---|---|
| Market cap | US$235.54m |
| Earnings (TTM) | -US$14.11m |
| Revenue (TTM) | US$49.58m |
Is SMDC.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SMDC.F income statement (TTM) | |
|---|---|
| Revenue | US$49.58m |
| Cost of Revenue | US$24.99m |
| Gross Profit | US$24.59m |
| Other Expenses | US$38.70m |
| Earnings | -US$14.11m |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
Sep 22, 2022
| Earnings per share (EPS) | -0.97 |
| Gross Margin | 49.60% |
| Net Profit Margin | -28.46% |
| Debt/Equity Ratio | 31.2% |
How did SMDC.F perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/09/18 03:44 |
| End of Day Share Price | 2022/06/21 00:00 |
| Earnings | 2021/12/31 |
| Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
SHL Telemedicine Ltd. is covered by 2 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Carla Bänziger | Bank Vontobel AG |
| Theodore O'Neill | Litchfield Hills Research, LLC |